Skip to the main content

VOYAGERS Health-Tech Fund

Founded 2020 Website LinkedIn
Cheque Size$100K to $2M
Stages3
Industries6
Markets19
Stated Portfolio2
Operating Since2020 (6y)

About VOYAGERS Health-Tech Fund

VOYAGERS Health-Tech Fund is a venture capital fund based in the United Kingdom, focusing on early-stage investments in health-tech and life sciences startups. The fund is part of the VOYAGERS community, a network of over 1,500 professionals from more than 30 countries committed to supporting each other in impactful projects. Through this community, the fund leverages extensive networks and expertise to identify and invest in startups with transformative potential in the healthcare sector. The fund's investment strategy targets companies that are solving significant healthcare problems using innovative technology or biotechnology. It typically invests in Pre-Seed, Seed, or Series A stages, with individual investments ranging from $100,000 to $1.5 million. The geographical focus includes the United Kingdom, United States, and several other countries, reflecting the global reach of the VOYAGERS community. Since its inception, the fund has made notable investments, including a $75,000 investment in 23 early-stage companies over a two-year period. One of its early successes was an investment in the mental-health startup Cerebral, which later raised funds at a valuation of $4.8 billion, significantly increasing the fund's initial investment. This track record demonstrates the fund's commitment to supporting innovative solutions in the health-tech sector and its ability to identify high-potential startups.

Investment Mandate

Investment Stages3

Asset Classes1

Geographical Focus

African markets1

Other stated markets18

United StatesUnited KingdomGermanyAustraliaItalyDenmarkSwitzerlandSpainIrelandPortugalSwedenBelgiumIsraelNorwayFinlandPeruIcelandUkraine

Requirements

Companies solving significant healthcare problems, Use of innovative technology or biotechnology, Led by mission-driven founders with strong ethics, Potential to become $100 million+ businesses, At Pre-Seed, Seed, or Series A stage, Fit within the VOYAGERS community

Stated Portfolio2

Baseimmune
Cerebral

As reported by the investor. We hold no profile for these companies, so they are printed as stated rather than linked.